MedPath

Post-exercise recovery after dietary protein ingestion in healthy young me

Completed
Conditions
age-related muscle loss
sarcopenia
10037008
10028302
Registration Number
NL-OMON37718
Lead Sponsor
Medisch Universitair Ziekenhuis Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
12
Inclusion Criteria

Males
Aged between 18-35 years
Healthy, recreationally active
BMI < 25 kg/m2

Exclusion Criteria

Smoking
Allergies to milk proteins (whey or casein)
Vegetarians
Female
Arthritic conditions
A history of neuromuscular problems
Previous participation in amino acid tracer studies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study endpoint is the muscle protein synthesis rate, expressed as<br /><br>fractional synthetic rate (FSR). In order to determine the FSR, the following<br /><br>parameters will be measured in blood and muscle tissue:<br /><br><br /><br>Plasma and muscle free phenylalanine concentration (expressed as *mol/L)<br /><br>Plasma enrichment of L-[ ring-2H5]phenylalanine (expressed as mole percent<br /><br>excess (MPE))<br /><br>Muscle protein bound enrichment of L-[ ring-2H5]phenylalanine (expressed as MPE)<br /><br>L-[ ring-2H5]phenylalanine enrichment of the muscle free amino acid pool<br /><br>(expressed as MPE)</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary endpoints include whole body protein turnover, protein digestion and<br /><br>absorption kinetics and nitrate/nitrite analysis. The following parameters will<br /><br>be calculated:<br /><br><br /><br>Exogenous phenylalanine rate of appearance and plasma availability of<br /><br>phenylalanine.<br /><br>Total rate of phenylalanine appearance and disappearance (= protein turnover)<br /><br>Endogenous phenylalanine rate of appearance (=protein breakdown)</p><br>
© Copyright 2025. All Rights Reserved by MedPath